Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for
the management of malignant and benign neoplasms. Detecting circulating DNA in cancer …

Multiple studies have investigated global DNA methylation profiles and gene-specific DNA
methylation in blood-based DNA to develop powerful screening markers for cancer. This …

Biological measures of aging are important for understanding the health of an aging
population, with epigenetics particularly promising. Previous studies found that tumor tissue …

During the twentieth century, genes were considered the controlling force of life processes,
and the transfer of DNA the definitive explanation for biological heredity. Such views shaped …

In recent years, cancer genomics has provided new insights into genetic alterations and
signaling pathways involved in thyroid cancer. However, the picture of the molecular …

Background Interest in the potential of DNA methylation in peripheral blood as a biomarker
of cancer risk is increasing. We aimed to assess whether epigenome-wide DNA methylation …

Sažetak Epigenetic mechanisms, such as DNA methylation, DNA hydroxymethylation, post-
translational modifications (PTMs) of histone proteins affecting nucleosome remodelling …

Background Recent studies highlight the role of DNA methylation in the pathogenesis of
Parkinson's disease (PD). However, there is a paucity of studies exploring the role of blood …

Qualitative and quantitative analysis of circulating cell-free DNA (cfDNA) is an emerging non-
invasive blood biomarker utilized to assess tumor progression and to evaluate prognosis …

Lung cancer is the leading cause of cancer-related deaths worldwide, and the 5-year
survival rate is still very poor due to the scarcity of effective tools for early detection. The …